| Literature DB >> 33350435 |
Thanh Minh Dang1,2,3, Trinh Van Le1,2, Huy Quang Do1,2, Van Thuan Nguyen2,3, Ai Xuan Le Holterman4, Loan Tung Thi Dang2,5, Nhan Chinh Lu Phan2,6, Phuc Van Pham1,2, Son Nghia Hoang7, Long Thanh Le7, Gabriele Grassi8, Nhung Hai Truong1,2,5.
Abstract
Liver fibrosis (LF) mortality rate is approximately 2 million per year. Irrespective of the etiology of LF, a key element in its development is the transition of hepatic stellate cells (HSCs) from a quiescent phenotype to a myofibroblast-like cell with the production of fibrotic proteins. It is necessary to define optimal isolation and culturing conditions for good HSCs yield and proper phenotype preservation for studying the activation of HSCs in vitro. In the present study, the optimal conditions of HSC isolation and culture were examined to maintain the HSC's undifferentiated phenotype. HSCs were isolated from Balb/c mice liver using Nycodenz, 8, 9.6, and 11%. The efficiency of the isolation procedure was evaluated by cell counting and purity determination by flow cytometry. Quiescent HSCs were cultured in test media supplemented with different combinations of fetal bovine serum (FBS), glutamine (GLN), vitamin A (vitA), insulin, and glucose. The cells were assessed at days 3 and 7 of culture by evaluating the morphology, proliferation using cell counting kit-8, lipid storage using Oil Red O (ORO) staining, expression of a-smooth muscle actin, collagen I, and lecithin-retinol acyltransferase by qRT-PCR and immunocytochemistry (ICC). The results showed that Nycodenz, at 9.6%, yielded the best purity and quantity of HSCs. Maintenance of HSC undifferentiated phenotype was achieved optimizing culturing conditions (serum-free Dulbecco's Modified Eagle's Medium (DMEM) supplemented with glucose (100 mg/dl), GLN (0.5 mM), vitA (100 μM), and insulin (50 ng/ml)) with a certain degree of proliferation allowing their perpetuation in culture. In conclusion, we have defined optimal conditions for HSCs isolation and culture.Entities:
Keywords: HSCs activation; Hepatic Stellate Cells; Nycodenz; Quiescent stellate cells; liver fibrosis
Mesh:
Substances:
Year: 2021 PMID: 33350435 PMCID: PMC7823195 DOI: 10.1042/BSR20202514
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840